Hims & Hers Health, Inc.
Hims & Hers Health, Inc. (HIMS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
hims · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Hims & Hers Health, Inc. (HIMS) measures how much investors pay for each dollar of the company's trailing earnings. HIMS's current PE ratio of N/A is calculated by dividing its stock price of $27.17 by its TTM earnings per share of -$0.06.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Equipment & Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Hims & Hers Health, Inc.You HIMS | $6.1B | N/A | — | -$0.06 |
 Align Technology, Inc. ALGN | $12.3B | 27.60x | -10.7% | $5.66 |
 Baxter International Inc. BAX | $9.9B | N/A | — | -$1.87 |
 BioMarin Pharmaceutical Inc. BMRN | $10.9B | 32.67x | +5.7% | $1.82 |
 The Ensign Group, Inc. ENSG | $9.1B | 29.02x | -6.1% | $6.00 |
 HealthEquity, Inc. HQY | $7.3B | 34.29x | +11.0% | $2.50 |
 Moderna, Inc. MRNA | $18.9B | N/A | — | -$7.25 |
Industry Average 4 peers with valid PE | — | 30.90x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 56.90x | $0.57 | +37.4% | |
2024-12-31 FY2024 | 41.43x | $0.58 | — | |
2023-12-31 FY2023 | — | $-0.11 | — | |
2022-12-31 FY2022 | — | $-0.32 | — | |
2021-12-31 FY2021 | — | $-0.58 | — | |
2020-12-31 FY2020 | — | $-0.51 | — | |
2019-12-31 FY2019 | — | $-2.07 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Hims & Hers Health, Inc. (HIMS) measures how much investors pay for each dollar of the company's trailing earnings. HIMS's current PE ratio of N/A is calculated by dividing its stock price of $27.17 by its TTM earnings per share of -$0.06.
Frequently asked questions
HIMS pe ratio · 6 questionsHIMS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $27.17 and TTM EPS of -$0.06. Data sourced from Financial Modeling Prep via HIMS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Hims & Hers Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08